Quris Company
Quris AI is tackling the most impactful AI challenge of our time: Predicting which drug candidates will safely work in humans. Quris’s machine-learning bio-platform predicts which drug candidates will safely work in humans.
Founded Date:
2019
Funding Status:
Seed
Total Funding:
37000000.0
Employee Number:
11-50
Headquarters:
Tel Aviv
Last Funding Date:
2022-12-20
Investors Number:
8.0
Last Funding Type:
Seed
Industry:
organ-on-a-chip